eprex 2000 i.e./0,5 ml raztopina za injiciranje v napolnjenih injekcijskih brizgah
johnson & johnson d.o.o. - epoetin alfa - raztopina za injiciranje - epoetin alfa 2000 i.e. / 0,5 ml - eritropoetin
eprex 20.000 i.e./0,5 ml raztopina za injiciranje v napolnjenih injekcijskih brizgah
johnson & johnson d.o.o. - epoetin alfa - raztopina za injiciranje - epoetin alfa 20000 i.e. / 0,5 ml - eritropoetin
tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastična sredstva - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.
doksorubicin teva 2 mg/ml koncentrat za raztopino za infundiranje
teva pharma b.v. - doksorubicin - koncentrat za raztopino za infundiranje - doksorubicin 1,88 mg / 1 ml - doksorubicin
doksorubicin teva 2 mg/ml koncentrat za raztopino za infundiranje
teva pharma b.v. - doksorubicin - koncentrat za raztopino za infundiranje - doksorubicin 1,88 mg / 1 ml - doksorubicin
doksorubicin teva 2 mg/ml koncentrat za raztopino za infundiranje
teva pharma b.v. - doksorubicin - koncentrat za raztopino za infundiranje - doksorubicin 1,88 mg / 1 ml - doksorubicin
doksorubicin teva 2 mg/ml koncentrat za raztopino za infundiranje
teva pharma b.v. - doksorubicin - koncentrat za raztopino za infundiranje - doksorubicin 1,88 mg / 1 ml - doksorubicin
livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - okužbe s citomegalovirusom - antivirusi za sistemsko uporabo - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). upoštevati je treba uradne smernice za ustrezno uporabo protivirusnih agenti.
binocrit
sandoz gmbh - epoetin alfa - anemia; kidney failure, chronic - antianemični preparati - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis;, treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e. srca in ožilja, stanja, predhodno obstoječe anemija na začetku kemoterapijo).
oksaliplatin regiomedica 5 mg/ml koncentrat za raztopino za infundiranje
regiomedica gmbh - oksaliplatin - koncentrat za raztopino za infundiranje - oksaliplatin 5 mg / 1 ml - oksaliplatin